Your browser doesn't support javascript.
loading
Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12.
Lee, Yun-Gyoo; Chang, Hyun; Keam, Bhumsuk; Chun, Sang Hoon; Park, Jihyun; Park, Keon Uk; Shin, Seong Hoon; An, Ho Jung; Lee, Kyoung Eun; Lee, Keun-Wook; Kim, Hye Ryun; Kim, Sung-Bae; Ahn, Myung-Ju; Hwang, In Gyu.
Affiliation
  • Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Chang H; Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.
  • Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Chun SH; Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
  • Park J; Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
  • Park KU; Department of Hemato-Oncology, Keimyung University Dongsan Medical Center, Daegu, Korea.
  • Shin SH; Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.
  • An HJ; Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Lee KE; Department of Hematology and Oncology, Ewha Womans University Hospital, Seoul, Korea.
  • Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Kim HR; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Kim SB; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Ahn MJ; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Hwang IG; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Cancer Res Treat ; 53(3): 671-677, 2021 Jul.
Article in En | MEDLINE | ID: mdl-33285051
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Squamous Cell Carcinoma of Head and Neck / Immune Checkpoint Inhibitors / Head and Neck Neoplasms / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Res Treat Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Squamous Cell Carcinoma of Head and Neck / Immune Checkpoint Inhibitors / Head and Neck Neoplasms / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Res Treat Year: 2021 Document type: Article Country of publication: